Enveric Biosciences, Inc. (ENVB) Gross margin 2014–2019
Enveric Biosciences, Inc. (ENVB) gross margin by fiscal year — reported gross profit divided by reported revenue.
20.4%FY2019 · since FY2014: 14.8% → 20.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 20.4% | -0.5 pp |
| FY2018 | 20.9% | -0.2 pp |
| FY2017 | 21.1% | +1.9 pp |
| FY2016 | 19.2% | -14.7 pp |
| FY2015 | 33.9% | +19.1 pp |
| FY2014 | 14.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice